Ethereum & Uniswap Surge: ETF Approval Boosts Prospectsby John Darbie 15.06.2024Spot Ethereum ETF approval boosts market amid Uniswap's Layer 2 growth; Crypto recovery led by ETH, UNI; Whale shifts $4.14M ...
Ethereum ETF Boost: Shiba Inu Soars Amid Memecoin Maniaby John Darbie 15.06.2024The Ethereum ETF’s impact on Shiba Inu (SHIB), rising institutional interest, and the surge in Solana's memecoins highlight crypto growth ...
‘Rich Dad Poor Dad’ Insights: Bitcoin’s Future Value Debateby John Darbie 15.06.2024Bitcoin's value soars, yet untapped potential remains with only 7% invested. Experts advise buying during gains, signaling BTC's ongoing dominance.
Altcoin Bloodbath: Analyst Highlights TON’s Ethereum Outperformanceby John Darbie 15.06.2024TON's daily active addresses, boosted by Telegram’s user base, surpassed Ethereum. Meme coins and AI outperformed, though major altcoins lagged.
SelfGoal: Advancing LLM AI for High-Level Goal Achievementby Lilu Anderson 15.06.2024Discover SELFGOAL, a non-parametric LLM approach using subgoal-driven Act Modules for high-level language tasks. Follow on Twitter, join ML SubReddit.
Win $10,000 USDT: Join Chimpzee NFT Passport Rewardsby John Darbie 15.06.2024Explore the exclusive Diamond NFT Passport with Chimpzee, offering $10,000 USDT prizes and expanded platform access. Purchase yours today!
BlockDAG’s X1 Miner Surge; Optimism’s $OP Dips Amid Whale Sell-Offby John Darbie 15.06.2024Optimism’s $OP token faces a 4.2% dip due to whale sell-off but boasts a $50.20K daily presale, peaking at $3M. ...
Investing in Israeli Tech: A Zionist Opportunity Amid Crisisby Mark Eisenberg 15.06.2024Israel's start-ups battered by war; 80% affected, 50% struggling with cash. Cukierman's platform offers hope as co-investments falter.
Schwab Exec Sells $600K+ in Stock, Exercises Optionsby Mark Eisenberg 15.06.2024Charles Schwab Corp. faces near-term challenges like 2% cash outflows in May; Goldman Sachs maintains Neutral rating with a $75.00 ...
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.